Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. - Wikidata - awgldk - TriplyDB

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

http://www.wikidata.org/entity/Q40509707

about

Aldosterone antagonists for preventing the progression of chronic kidney disease Aldosterone antagonists for preventing the progression of chronic kidney disease Supramaximal dose of candesartan in proteinuric renal disease Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy Recent advances in managing and understanding diabetic nephropathy Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy Assessing the Validity of Surrogate Outcomes for ESRD: A Meta-Analysis Present and future in the treatment of diabetic kidney disease Monitoring kidney function and albuminuria in patients with diabetes.Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review Improvements in the Management of Diabetic Nephropathy Renal autoregulation in health and disease The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy Involvement of endoplasmic reticulum stress in albuminuria induced inflammasome activation in renal proximal tubular cells Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders The relationship between proteinuria and coronary risk: a systematic review and meta-analysis Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.Grape seed powder improves renal failure of chronic kidney disease patients.Paeoniflorin prevents diabetic nephropathy in rats.Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study.Comparison of spironolactone and trichlormethiazide as add-on therapy to renin-angiotensin blockade for reduction of albuminuria in diabetic patients Dual blockade of the renin-angiotensin system in diabetic nephropathy.Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors Avosentan for overt diabetic nephropathy.Proteinuria, (99m) Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease.Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR.Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis Optimal proteinuria target for renoprotection in patients with IgA nephropathy.Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SB Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study.Comparison of different measures of urinary protein excretion for prediction of renal events.Implementation of a CKD checklist for primary care providers Hypertensive nephropathy: prevention and treatment recommendations.

P2860

Q24194979-8218CECE-86AE-4C0B-B636-6A1F5CCEDC6E Q24239909-0FDF308B-D806-4369-92EE-CE2C2785F879 Q24649685-EA4B98F3-8D51-41E0-95AA-21F2EF608CAF Q24657470-FA50E300-3465-44AF-AD33-FB32206696EA Q26745900-C27DF4FF-120B-4930-8DB2-B819D41D99BA Q26747131-AC378A5D-BC4E-4819-9014-D9284B163F1A Q26769787-D857AB22-75BC-4097-8EC9-002ADBDFD643 Q26863404-A5E23A47-EB03-4A55-AB9B-58DE0AAF24D4 Q26864133-E85BA33C-915C-4AD8-A511-0CAAD2AE4587 Q27691297-EB97664A-E9B8-4D86-AA73-980B07BC2507 Q28079134-59A78A5C-45A2-4C61-80A4-CDB05D30FE93 Q28080717-A2EE5D3E-3C9A-41E5-AD72-E46BCFACEA0F Q28082365-8C91B2EB-0933-47A3-AEE2-020E348C6C36 Q28237978-D24CE244-444D-4888-BEAE-F6BB07F56393 Q28535453-10B3EFE8-162C-4536-B82E-F0B9364A073D Q33166521-580BE170-F68B-46FF-93C1-618FFE1889A9 Q33378672-A91F6950-6D05-44FB-8E5D-14D27D5F5B5C Q33414957-3EE7104F-6C8C-4A7F-AFE1-2CB8F6A00BDC Q33436604-E34F84AA-9C2C-4567-81EF-423673F03E66 Q33560342-25313D8B-C6FC-48A9-A533-9789C93563CA Q33576711-B2E53AF3-BE40-44DE-8645-9DB116F7A3BC Q33585122-C202B818-2617-4E7F-9E18-18E918416CC3 Q33588053-C1E34C8B-D9A6-463C-BF3B-912D48F8348C Q33588914-897F6B49-A98B-4BB9-BF73-0D1E817B7C3E Q33610694-342B0592-31E4-4DE0-8EC5-6F9FA8CD7DF8 Q33698419-E79DFD3D-ECC7-4395-957C-E036B56EE7BF Q33702404-63821697-8DCC-45A5-8391-513168BBAEFA Q33710875-CC3CE621-3121-4581-8CDD-A49FE0D36562 Q33727755-914840D5-203A-4CC4-9EAC-433A2D1FF53A Q33737225-818986E7-FD59-4BFB-BC08-474F17674F83 Q33772238-4CB5C637-3F8C-4797-8FF8-4B1D21711F5B Q33794256-43364C11-F405-415C-B2AD-7226495A6847 Q33805412-37A079DE-6333-4000-8F9B-FB5995D9D774 Q33864287-4E166D53-17FB-4659-A95C-B1898BE38D82 Q33899286-70CCA866-DD93-4A0A-9A34-BBE9B00CFA4B Q33908782-34C63E99-93FE-4EDB-876D-87CFA7F575D2 Q34071671-3CE98C04-E8D3-48B0-9024-ADD28B8FFEFD Q34124213-291BB44A-3731-4A78-B08B-3D7FC55D2F99 Q34124728-E80E4B31-6B97-4144-99DC-2FF8DFC3933D Q34131899-B492B6DA-AC84-4910-8D48-73801AD40811

P2860

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

http://www.wikidata.org/entity/Q40509707

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.

@en

type

label

Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.

@en

prefLabel

Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.

@en

P1433

Q40509707-8070D819-0395-44A2-8003-ABA7B40AE3C0

P1476

Q40509707-7009F600-0998-414B-9913-2A5781F2560F

P2093

Q40509707-02332EE5-3128-4EDA-A813-E287B7772B48

Q40509707-2E141C91-2C0D-4EC3-A51D-0A6D577C44C2

Q40509707-6A0BD024-4D37-4E1D-B52E-CBD140D50AE4

Q40509707-7F0C6379-A84D-4014-9EF0-C1C0D33319AD

Q40509707-986C629D-E037-48CA-A5C8-3A8C2A073D3C

Q40509707-9FD5A4F9-93F1-4A35-BE9B-D72967B385D7

Q40509707-BA11D4BD-532F-4268-ABCB-E00654728420

Q40509707-E190702C-B67B-423A-857A-DC9478E06712

Q40509707-FD57A3D4-0F86-476A-87E0-6E4A836A7830

P2888

Q40509707-8B0EC8DE-2601-4C9B-A121-017A0CF04F0D

P304

Q40509707-4AE90B90-9BFD-4093-9DDA-8C706169C058

P31

Q40509707-77EF6DB6-D1CB-4F85-91E6-48D69ADF73A7

P356

Q40509707-049DE5B1-F737-4125-9027-0EED94981725

P407

Q40509707-5FBB7D0A-0E4C-47AB-A49B-9927285AA984

P433

Q40509707-A0D8FEAA-324F-4653-8DDA-43E422E24DCD

P478

Q40509707-25AAB7B2-651B-40AC-8FD4-BD14EEBEF763

P50

Q40509707-4538522E-F317-4249-A653-B04DA9AAB8BE

P577

Q40509707-31483AB4-38EB-4E05-B287-7E922F598DBE

P5875

Q40509707-38423656-AF53-4CBA-B14F-2C968D3FE8AE

P6179

Q40509707-D00358C7-07D1-442E-91E5-BBE08C4FD541

P698

Q40509707-F5ECD5C5-AE21-4D7E-9DC9-55487703A966

P356

J.1523-1755.2004.00653.X

P1433

Kidney International

P1476

Proteinuria, a target for reno ...... hropathy: lessons from RENAAL.

@en

P2093

Barry M Brenner

http://www.w3.org/2001/XMLSchema#string

Dick de Zeeuw

http://www.w3.org/2001/XMLSchema#string

Hans-Henrik Parving

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Shahnaz Shahinfar

http://www.w3.org/2001/XMLSchema#string

Steve Snapinn

http://www.w3.org/2001/XMLSchema#string

William E Mitch

http://www.w3.org/2001/XMLSchema#string

William F Keane

http://www.w3.org/2001/XMLSchema#string

Zhongxin Zhang

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2004.00653.x

P304

2309-2320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1523-1755.2004.00653.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8557543

http://www.w3.org/2001/XMLSchema#string

P6179

1044734909

http://www.w3.org/2001/XMLSchema#string

P698

15149345

http://www.w3.org/2001/XMLSchema#string